Moreover, we observed enhanced antigen presentation with upregulation of both MHC class I and II (HLA-ABC, HLA-DR) molecules and increased expression of PD-L1 on tumor cells in the combination treated mice. The gene discussed is CD274; the disease is neoplasm.